Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PFS...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 35; no. 29; p. 3279
Main Authors:	McCarthy, Philip L, Holstein, Sarah A, Petrucci, Maria Teresa, Richardson, Paul G, Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C, Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D, Palumbo, Antonio, Attal, Michel
Format:	Journal Article
Language:	English
Published:	United States 10.10.2017
Subjects:	Adult Aged Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Chemotherapy, Adjuvant Disease Progression Disease-Free Survival Drug Administration Schedule Female Humans Kaplan-Meier Estimate Lenalidomide Maintenance Chemotherapy Male Middle Aged Multiple Myeloma - diagnosis Multiple Myeloma - mortality Multiple Myeloma - therapy Randomized Controlled Trials as Topic Risk Factors Stem Cell Transplantation - adverse effects Stem Cell Transplantation - mortality Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - analogs & derivatives Time Factors Transplantation, Autologous Treatment Outcome Young Adult
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!